P-267: Subcutaneous Isatuximab Administration by an On-Body Delivery System in Combination with Pomalidomide-Dexamethasone in Relapsed/refractory Multiple Myeloma Patients: Interim Phase 1b Study Results
Clinical Lymphoma Myeloma and Leukemia（2022）
Key words
International Myeloma Working Group
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined